Entacapone Augmentation for Schizophrenia

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rambam Health Care Campus
• Treatments: Entacapone

Criteria

Inclusion Criteria:

• predominantly negative symptoms

• stable on ongoing antipsychotic treatment

Exclusion Criteria:

• acute psychotic exacerbation

• suicidal ideation

• uncontrolled systemic disease